During preeclampsia, patients have increased serum levels of vasoconstrictors such as endothelin 1 (ET-1) and thromboxane [62–64], while the responsiveness to vasodilators including nitric oxide (NO) and prostacyclin is significantly reduced in vivo [65–67]. The gene discussed is EDN1; the disease is preeclampsia.